These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38286082)

  • 1. Computational prediction for designing novel ketonic derivatives as potential inhibitors for breast cancer: A trade-off between drug likeness and inhibition potency.
    Muhammad S; Zahir N; Bibi S; Alshahrani MY; Shafiq-urRehman ; Chaudhry AR; Sarwar F; Tousif MI
    Comput Biol Chem; 2024 Apr; 109():108020. PubMed ID: 38286082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designing and optimization of novel human LMTK3 inhibitors against breast cancer - a computational approach.
    Anbarasu K; Jayanthi S
    J Recept Signal Transduct Res; 2017 Feb; 37(1):51-59. PubMed ID: 27056562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand and structure based virtual screening of chemical databases to explore potent small molecule inhibitors against breast invasive carcinoma using recent computational technologies.
    Agarwal S; Dixit A; Kashaw SK
    J Mol Graph Model; 2020 Jul; 98():107591. PubMed ID: 32234678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the New Inhibitors by Sulfadiazine and Modified Derivatives of α-D-glucopyranoside for White Spot Syndrome Virus Disease of Shrimp by In Silico: Quantum Calculations, Molecular Docking, ADMET and Molecular Dynamics Study.
    Kumer A; Chakma U; Rana MM; Chandro A; Akash S; Elseehy MM; Albogami S; El-Shehawi AM
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35744817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the potential of novel phenolic compounds as potential therapeutic candidates against SARS-CoV-2, using quantum chemistry, molecular docking and dynamic studies.
    Zia M; Muhammad S; Shafiq-urRehman ; Bibi S; Abbasi SW; Al-Sehemi AG; Chaudhary AR; Bai FQ
    Bioorg Med Chem Lett; 2021 Jul; 43():128079. PubMed ID: 33940136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring Radioiodinated Anastrozole and Epirubicin as AKT1-Targeted Radiopharmaceuticals in Breast Cancer: In Silico Analysis and Potential Therapeutic Effect with Functional Nuclear Imagining Implications.
    Binmujlli MA
    Molecules; 2024 Sep; 29(17):. PubMed ID: 39275052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A drug design strategy based on molecular docking and molecular dynamics simulations applied to development of inhibitor against triple-negative breast cancer by Scutellarein derivatives.
    Akash S; Aovi FI; Azad MAK; Kumer A; Chakma U; Islam MR; Mukerjee N; Rahman MM; Bayıl I; Rashid S; Sharma R
    PLoS One; 2023; 18(10):e0283271. PubMed ID: 37824496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational Screening of Some Phytochemicals to Identify Best Modulators for Ligand Binding Domain of Estrogen Receptor Alpha.
    Alagarsamy V; Sundar PS; Solomon VR; Murugesan S; Muzaffar-Ur-Rehman M; Kulkarni VS; Sulthana MT; Narendhar B; Sabarees G
    Curr Pharm Des; 2024; 30(20):1599-1609. PubMed ID: 38698754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and molecular dynamics simulation studies of quinoline derivatives as protease inhibitors against SARS-CoV-2.
    Singh VK; Chaurasia H; Kumari P; Som A; Mishra R; Srivastava R; Naaz F; Singh A; Singh RK
    J Biomol Struct Dyn; 2022; 40(21):10519-10542. PubMed ID: 34253149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the inhibitory potential of novel piperidine-derivatives against main protease (M
    Rafique A; Muhammad S; Iqbal J; Al-Sehemi AG; Alshahrani MY; Ayub K; Gilani MA
    J Mol Liq; 2023 Jul; 382():121904. PubMed ID: 37151376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of novel natural compound inhibitors targeting estrogen receptor α by an integrated virtual screening strategy.
    Yu E; Xu Y; Shi Y; Yu Q; Liu J; Xu L
    J Mol Model; 2019 Aug; 25(9):278. PubMed ID: 31463793
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Bouricha EM; Hakmi M; Akachar J; Zouaidia F; Ibrahimi A
    J Biomol Struct Dyn; 2022 Jul; 40(11):5203-5210. PubMed ID: 33402049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel computational and drug design strategies for inhibition of human papillomavirus-associated cervical cancer and DNA polymerase theta receptor by Apigenin derivatives.
    Akash S; Bayıl I; Hossain MS; Islam MR; Hosen ME; Mekonnen AB; Nafidi HA; Bin Jardan YA; Bourhia M; Bin Emran T
    Sci Rep; 2023 Oct; 13(1):16565. PubMed ID: 37783745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico analysis of potential inhibitors for breast cancer targeting 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) catalyses.
    Islam MR; Tayyeb JZ; Paul HK; Islam MN; Oduselu GO; Bayıl I; Abdellattif MH; Al-Ahmary KM; Al-Mhyawi SR; Zaki MEA
    J Cell Mol Med; 2024 Aug; 28(15):e18584. PubMed ID: 39135338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QSAR, ADMET, molecular docking, and dynamics studies of 1,2,4-triazine-3(2H)-one derivatives as tubulin inhibitors for breast cancer therapy.
    Moussaoui M; Baammi S; Soufi H; Baassi M; El Allali A; Belghiti ME; Daoud R; Belaaouad S
    Sci Rep; 2024 Jul; 14(1):16418. PubMed ID: 39013949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computer-aided discovery of novel SmDHODH inhibitors for schistosomiasis therapy: Ligand-based drug design, molecular docking, molecular dynamic simulations, drug-likeness, and ADMET studies.
    Ja'afaru SC; Uzairu A; Hossain S; Ullah MH; Sallau MS; Ndukwe GI; Ibrahim MT; Bayil I; Moin AT
    PLoS Negl Trop Dis; 2024 Sep; 18(9):e0012453. PubMed ID: 39264908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of ligand binding affinity and orientation of xenoestrogens to the estrogen receptor by molecular dynamics simulations and the linear interaction energy method.
    van Lipzig MM; ter Laak AM; Jongejan A; Vermeulen NP; Wamelink M; Geerke D; Meerman JH
    J Med Chem; 2004 Feb; 47(4):1018-30. PubMed ID: 14761204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elucidation of Agonist and Antagonist Dynamic Binding Patterns in ER-α by Integration of Molecular Docking, Molecular Dynamics Simulations and Quantum Mechanical Calculations.
    Sakkiah S; Selvaraj C; Guo W; Liu J; Ge W; Patterson TA; Hong H
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unveiling the Anti-Cancer Potential of Onoceranoid Triterpenes from
    Hardianto A; Mardetia SS; Destiarani W; Budiman YP; Kurnia D; Mayanti T
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Helicobacter pylori-carcinogenic TNF-alpha-inducing protein inhibitors via daidzein derivatives through computational approaches.
    Tayyeb JZ; Mondal S; Anisur Rahman M; Kumar S; Bayıl I; Akash S; Hossain MS; Alqahtani T; Zaki MEA; Oliveira JIN
    J Cell Mol Med; 2024 May; 28(9):e18358. PubMed ID: 38693868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.